
February 10, 2026
Synthetic lymph node brings new fight to cancer care
A dime-sized technology could transform CAR-T therapy by creating a simpler, more affordable procedure that targets many cancer types and can be done at almost any hospital.

February 10, 2026
A dime-sized technology could transform CAR-T therapy by creating a simpler, more affordable procedure that targets many cancer types and can be done at almost any hospital.

February 4, 2026
Research from Kay Chung, PhD, and colleagues reveal new strategies for sustaining immune memory while preserving the ability to fight cancer and infections. The findings have broad implications for immunotherapy and infectious disease research.

January 28, 2026
Gynecologic oncologist Olivia Lara, MD, shares what you need to know about endometrial cancer, the fourth most common cancer for women in the United States.

January 27, 2026
Allison Lazard, PhD, and Melissa Gilkey, PhD, will co-lead the UNC Lineberger Cancer Prevention and Control Program, joining long-time program co-leader Ethan Basch, MD, MSc, FASCO.

January 23, 2026
John Mote's doctors jumped into action when longtime surveillance revealed cancer.

January 8, 2026
A new study is highlighting a simple but effective way to improve women’s health screenings for women who are often missed by traditional programs.

January 7, 2026
Prostate cancer is the most common cancer in men. Urologic oncologist Matt Nielsen, MD, MS, FACS, shares three things to know about prostate cancer.

January 6, 2026
Researchers with the UNC Institute for Global Health and Infectious Diseases, in collaboration with the UNC Lineberger and UNC Project-Malawi, found adults receiving rituximab as part of cancer treatment face a significantly higher risk of developing symptomatic malaria in an endemic region.

January 6, 2026
The research, led by Nobel laureate and biochemist Aziz Sancar, MD, PhD, could revolutionize treatments for glioblastoma, an aggressive and deadly form of brain cancer.

January 5, 2026
Harrison brings more than three decades of experience providing senior and executive-level research administrative leadership for cancer centers that have achieved and maintained the prestigious NCI designation.